Skip to main content
. 2014 Apr;88(7):3850–3860. doi: 10.1128/JVI.03456-13

FIG 7.

FIG 7

Encapsidation and cytidine deaminase activity of mA3s with mutations altering putative phosphorylation sites. mA3 mutants were tested for encapsidation into ΔVif HIV-1 (a) or MLV (b) particles, as described previously (9, 15). (c) Mutant and wild-type His-GST-mA3-HA preparations were tested using the oligodeoxynucleotide with 3 target sites.